Abstract
Gout is the most common inflammatory arthritis In the elderly population. Management in the elderly requires special consideration. Physiologic changes associated with aging and co-morbidities make the elderly prone to adverse effects of drugs otherwise successfully used in younger counterparts. Use of colchicine, non-steroidal anti-inflammatory drugs, and urate-lowering therapies may be restricted in those with limited renal reserve. Corticosteroids are safe alternatives for short-term use in acute gout. Elderly patients need laboratory monitoring for side effects more frequently than usual. Non-pharmacologic measures such as dietary modifications, regular exercise, and Ice therapy should be considered vital adjunctive treatments. A brief review of future therapies is also discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 13-20 |
| Number of pages | 8 |
| Journal | Geriatrics |
| Volume | 63 |
| Issue number | 7 |
| State | Published - Jul 2008 |
ASJC Scopus Subject Areas
- Geriatrics and Gerontology
Keywords
- Elderly
- Gout
- Hyperuricemia